IP Library › Granted Patent US 7,125,700
Granted Patent B2
US 7,125,700 · App. 10/348,155 · Granted Oct 24, 2006

Cyclic GMP dependent protein kinase as a chemotherapeutic target for antiprotozoal agents

View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 7,125,700
App. No.
10/348,155
Granted
Oct 24, 2006
Kind
B2
Abstract

Protozoal cyclic GMP dependent protein kinases have been isolated and cloned. These enzymes may be used in screening assays to identify potential antiprotozoal agents.

Claims (1)

1. A substantially pure cGMP dependent protein kinase polypeptide comprising the amino acid sequence encoded by the nucleotide sequence set forth in SEQ ID NO:10.

Assignments (1)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Mar 8, 2010
From: MERCK & CO.
To: MERIAL LIMITED
Reel/Frame 024045/0175 →